ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.
Metrics to compare | AGLI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAGLIPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.7x | 26.7x | −0.7x | |
PEG Ratio | −0.16 | 0.34 | 0.00 | |
Price/Book | 0.6x | 3.4x | 2.6x | |
Price / LTM Sales | 0.4x | 2.2x | 3.3x | |
Upside (Analyst Target) | - | 18.8% | 39.6% | |
Fair Value Upside | Unlock | 1.0% | 6.0% | Unlock |